Table 2.
Summary of studies showing conflicting evidence about the role of IL-22 in asthma murine models.
| Study | Murine Model | Allergen | Route of sensitization | Method to study IL-22 effects | Phase of allergic inflammation investigated | Global effect of IL-22 | Effect of IL-22 on Th2 cytokines | Effect of IL-22 on IL-17 | Effect on eosinophilic inflammation | Effect on neutrophilic inflammation | Effect on AHR | Effect on airway remodeling |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takahashi et al. (127) | Balb/c | OVA | Ip | Anti-IL22 Ab | Se+Chal | Protective | ↓ | ↓ | ||||
| Taube et al. (128) | C57BL/6 | OVA | Ip | IL-22 KO | •Se+Chal •Chal wo Se |
Protective during Se | ↓ | ↓ | ||||
| Nakagome et al. (129) | Balb/c | OVA | Ip | •IL-22BP •Inducible-IL-22 expression |
•Se •Se+Chal |
Protective during Se | ↓ only during Se | ↓ (mucus) only during Se | ||||
| Besnard et al. (99) | C57BL/6 | OVA | Sc | •Anti-IL22 Ab •IL-22 KO |
•Se •Se+Chal |
•Pro-inflammatory during Se •Protective during Chal |
↑ only during Se | ↓ | ↑ only during Se | ↑ only during Se | ↑ (mucus) only during Se | |
| Fang et al. (130) | C57BL/6 | OVA | Ip | •Lung-inducible IL-22 expression |
Se+Chal | Protective | ↓ | ↓ | ↓ | ↓ (mucus) | ||
| Ito et al. (131) | C57BL/6 | HDM | Intratracheal | IL-22 KO | Se+Chal | Protective | ↓ | ↓ | ↓ | |||
| Leyva-Castillo et al. (132) | Balb/c | OVA | •Ec •Ip |
•Anti-IL22 Ab •IL-22 KO |
Se+Chal | Pro-inflammatory with Ec Se | ↑ (only after Ec Se) | ↑ (requires TNFα) only after Ec Se) | ↑ only after Ec Se |
OVA, ovalbumin; HDM, house dust mite; Ip, intraperitoneal; Sc, subcutaneous; Ec, epicutaneous; Ab, antibody; KO, knock out gene; IL-22BP, IL-22 Binding Protein; Se, allergen sensitization; Chal, allergen challenge; wo, without; AHR, airway hyperresponsiveness.